Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $862,980 (100.0% shares, 0.0% debt)

Holdings (39)

INSM INSMED INC 16.6%
Value ($000) $143,311 Shares 2,138,963 Est. Cost $17.79 Unrealized +118.0%
BMRN BIOMARIN PHARMACEUTICAL INC 10.8%
Value ($000) $93,047 Shares 1,130,167 Est. Cost $83.16 Unrealized +0.1%
FOLD AMICUS THERAPEUTICS INC 10.4%
Value ($000) $89,576 Shares 9,029,843 Est. Cost $9.63 Unrealized +6.6%
UTHR UNITED THERAPEUTICS CORP 9.9%
Value ($000) $85,025 Shares 266,914 Est. Cost $89.23 Unrealized +196.6%
BIIB BIOGEN INC 7.8%
Value ($000) $67,008 Shares 289,050 Est. Cost $264.98 Unrealized -18.0%
STAA STAAR SURGICAL CO 7.6%
Value ($000) $65,779 Shares 1,381,619 Est. Cost $24.23 Unrealized +80.8%
ALNYLAM PHARMACEUTICALS INC 5.2%
Value ($000) $44,499 Shares 183,123 Est. Cost $243.00 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 4.6%
Value ($000) $39,306 Shares 2,418,841 Est. Cost $28.41 Unrealized -43.2%
PRTA PROTHENA CORP PLC 4.0%
Value ($000) $34,394 Shares 1,666,378 Est. Cost $21.46 Unrealized +0.9%
SRPT SAREPTA THERAPEUTICS INC 3.7%
Value ($000) $31,866 Shares 201,683 Est. Cost $111.32 Unrealized +15.4%
ANAB ANAPTYSBIO INC 2.3%
Value ($000) $20,139 Shares 803,641 Est. Cost $19.13 Unrealized +21.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 2.0%
Value ($000) $16,974 Shares 2,116,403 Est. Cost $5.23 Unrealized +104.8%
REVANCE THERAPEUTICS INC 1.6%
Value ($000) $13,511 Shares 5,257,086 Est. Cost $21.40 Unrealized
ALKS ALKERMES PLC 1.4%
Value ($000) $11,944 Shares 495,592 Est. Cost $22.36 Unrealized +9.7%
SAGE THERAPEUTICS INC 1.3%
Value ($000) $10,978 Shares 1,010,833 Est. Cost $42.50 Unrealized
EHTH EHEALTH INC 1.2%
Value ($000) $10,646 Shares 2,350,190 Est. Cost $38.13 Unrealized -86.8%
NVCR NOVOCURE LTD 1.1%
Value ($000) $9,625 Shares 561,908 Est. Cost $58.84 Unrealized -70.1%
ALGN ALIGN TECHNOLOGY INC 1.1%
Value ($000) $9,119 Shares 37,772 Est. Cost $149.18 Unrealized +86.6%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value ($000) $8,319 Shares 405,193 Est. Cost $16.84 Unrealized +24.3%
ACELYRIN INC 0.9%
Value ($000) $7,564 Shares 1,715,180 Est. Cost $6.75 Unrealized
NEVRO CORP 0.7%
Value ($000) $6,318 Shares 750,371 Est. Cost $21.87 Unrealized
CYTK CYTOKINETICS INC 0.7%
Value ($000) $6,053 Shares 111,717 Est. Cost $6.71 Unrealized +799.1%
GOSS GOSSAMER BIO INC 0.7%
Value ($000) $5,655 Shares 6,277,093 Est. Cost $1.58 Unrealized -52.6%
ELEVATION ONCOLOGY INC 0.6%
Value ($000) $4,860 Shares 1,800,106 Est. Cost $4.52 Unrealized
BLUEBIRD BIO INC 0.5%
Value ($000) $4,560 Shares 4,633,351 Est. Cost $1.35 Unrealized
KARYOPHARM THERAPEUTICS INC 0.5%
Value ($000) $4,427 Shares 5,102,193 Est. Cost $16.36 Unrealized
VERVE THERAPEUTICS INC 0.3%
Value ($000) $2,810 Shares 575,817 Est. Cost $13.94 Unrealized
NUVB NUVATION BIO INC 0.3%
Value ($000) $2,256 Shares 772,652 Est. Cost $1.92 Unrealized +58.9%
MIRM MIRUM PHARMACEUTICALS INC 0.3%
Value ($000) $2,212 Shares 64,700 Est. Cost $15.56 Unrealized +68.5%
RLMD RELMADA THERAPEUTICS INC 0.3%
Value ($000) $2,197 Shares 732,400 Est. Cost $3.27 Unrealized +10.6%
TSHA TAYSHA GENE THERAPIES INC 0.2%
Value ($000) $1,817 Shares 811,268 Est. Cost $2.02 Unrealized +43.7%
STOK STOKE THERAPEUTICS INC 0.2%
Value ($000) $1,700 Shares 125,861 Est. Cost $6.06 Unrealized +122.9%
HUM HUMANA INC 0.2%
Value ($000) $1,489 Shares 3,985 Est. Cost $369.63 Unrealized -10.7%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value ($000) $910 Shares 110,719 Est. Cost $23.56 Unrealized -71.4%
VYNE VYNE THERAPEUTICS INC PIPE 0.1%
Value ($000) $878 Shares 445,434 Est. Cost $3.12 Unrealized -20.0%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value ($000) $746 Shares 225,465 Est. Cost $5.95 Unrealized -34.1%
ACRS ACLARIS THERAPEUTICS INC 0.1%
Value ($000) $627 Shares 569,832 Est. Cost $1.19 Unrealized -1.5%
GENERATION BIO CO 0.0%
Value ($000) $424 Shares 150,475 Est. Cost $2.82 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $411 Shares 24,500 Est. Cost $27.01 Unrealized -47.3%